Application of magnetic iron oxide nanoparticles: Thrombotic activity, imaging and cytocompatibility of silica-coated and carboxymethyl dextrane-coated particles

• Published in: Colloids and surfaces, B, Biointerfaces B, Biointerfaces, 2023-08, Vol.228, p.113428-113428, Article 113428
• Main Authors: Turrina, Chiara, Schoenen, Max, Milani, Davide, Klassen, Anna, Rojas Gonzaléz, Diana M., Cvirn, Gerhard, Mela, Petra, Berensmeier, Sonja, Slabu, Ioana, Schwaminger, Sebastian P.
• Format: Article
• Language: English
• Subjects: Agglomeration behavior; Coagulation; Humans; Ions; Iron oxide nanoparticles; Magnetic Iron Oxide Nanoparticles; Magnetic resonance imaging; Magnetic separation; Magnetite Nanoparticles; Nanomedicine; Nanoparticles; Particle Size; Silicon Dioxide
• ISSN: 0927-7765; 1873-4367
• DOI: 10.1016/j.colsurfb.2023.113428

Coated iron oxide nanoparticles (IONs) are promising candidates for various applications in nanomedicine, including imaging, magnetic hyperthermia, and drug delivery. The application of IONs in nanomedicine is influenced by factors such as biocompatibility, surface properties, agglomeration, degradation behavior, and thrombogenicity. Therefore, it is essential to investigate the effects of coating material and thickness on the behavior and performance of IONs in the human body. In this study, IONs with a carboxymethyl dextran (CMD) coating and two thicknesses of silica coating (TEOS0.98, and TEOS3.91) were screened and compared to bare iron oxide nanoparticles (BIONs). All three coated particles showed good cytocompatibility (>70%) when tested with smooth muscle cells over three days. To investigate their potential long term behavior inside the human body, the Fe2+ release and hydrodynamic diameters of silica-coated and CMD (carboxymethyl dextrane)-coated IONs were analyzed in simulated body fluids for 72 h at 37 °C. The ION@CMD showed moderate agglomeration of around 100 nm in all four simulated fluids and dissolved faster than the silica-coated particles in artificial exosomal fluid and artificial lysosomal fluid. The particles with silica coating agglomerated in all tested simulated media above 1000 nm. Increased thickness of the silica coating led to decreased degradation of particles. Additionally, CMD coating resulted in nanoparticles with the least prothrombotic activity, and the thick silica coating apparently decreased the prothrombotic properties of nanoparticles compared to BIONs and ION@TEOS0.98. For magnetic resonance applications, ION@CMD and ION@TEOS3.91 showed comparatively high relaxation rates R2 values. In magnetic particle imaging experiments ION@TEOS3.91 yielded the highest normalized signal to noise ratio values and in magnetic hyperthermia studies, ION@CMD and ION@TEOS0.98 showed similar specific loss power. These findings demonstrate the potential of coated IONs in nanomedicine and emphasize the importance of understanding the effect of coating material and thickness on their behavior and performance in the human body. [Display omitted] •Coating of iron oxide nanoparticles determines their use for magnetic resonance imaging.•Carboxymethyl dextrane coated particles do not affect the coagulation of whole blood.•Dissolution kinetics of iron oxide nanoparticles according to their coating.•Carboxymethyl dextrane coated particles for hype